Clinical Trial Update: (PGA) for Platinum-resistant/Refractory, Paclitaxel-Pretreated Recurrent Ovarian and Peritoneal Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 trial update for platinum-resistant/refractory, paclitaxel-pretreated recurrent ovarian and peritoneal carcinoma; study terminated with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fallopian Tube Carcinoma
• Ovarian Carcinoma
• Peritoneal Carcinoma

Snippet

Sponsor: Western Regional Medical Center | Conditions: Ovarian Carcinoma, Fallopian Tube Carcinoma | Phase 2 | Status: TERMINATED | Results posted: 2017-10-25